Causes of mortality following PCI: the University of New Mexico hospital experience

Yusra Azhar1, Kenneth M Zabel1, James C Blankenship2

  • 1Department of Internal Medicine.

Coronary Artery Disease
|December 18, 2024
PubMed

Insights

Mortality after percutaneous coronary intervention (PCI) is linked to patient instability before the procedure. Identifying specific causes of death is crucial for improving outcomes in high-risk PCI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Informatics

Background:

  • Mortality following percutaneous coronary intervention (PCI) remains a significant clinical challenge.
  • Existing clinical databases lack detailed information on specific causes of death post-PCI, hindering the identification of improvement opportunities.
  • This study aimed to identify specific opportunities for improvement (OFIs) by reviewing cases of death after coronary intervention.

Purpose of the Study:

  • To investigate the causes of death in patients undergoing percutaneous coronary intervention (PCI).
  • To identify specific opportunities for improvement (OFIs) that could potentially prevent mortality after PCI.
  • To analyze patient presentation, procedural success, and complications in relation to mortality.

Main Methods:

  • Utilized the University of New Mexico's electronic medical record system to identify PCI patients who died before discharge between January 1, 2019, and June 30, 2021.
  • Conducted a thorough review of electronic medical records by two physicians for each deceased patient.
  • Evaluated patient presentation, PCI procedural success, PCI-related complications, their contribution to death, and the ultimate causes of death.

Main Results:

  • Out of 894 PCI patients, 48 (5.4%) died before discharge.
  • The most common presentations were ST-elevation myocardial infarction (48%) and out-of-hospital cardiac arrest (35%).
  • The overall procedural success rate for PCI was 90%, with cardiac causes being the most frequent cause of death (80%).

Conclusions:

  • Deaths after PCI in this cohort occurred in critically ill patients with pre-existing conditions like myocardial infarction or cardiac arrest.
  • Percutaneous coronary intervention successfully reduced culprit stenosis in most cases with a high procedural success rate and minimal complications.
  • No deaths were definitively attributed to operator error, suggesting focus on patient acuity and underlying conditions.
Abstract

Related Concept Videos

Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...